TREATMENT BENEFITS ASSOCIATED WITH OPEN LABEL ORAL...

CHEST Journal 2019 / 10 Vol. 156; Iss. 4

TREATMENT BENEFITS ASSOCIATED WITH OPEN LABEL ORAL TREPROSTINIL AFTER CLINICAL WORSENING IN THE PHASE 3 FREEDOM-EV STUDY FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

White, R., Grünig, Ekkehard, Jerjes-Sanchez, Carlos, Meyer, Gisela, Pulido, Tomás, SEPULVEDA, PABO, Wang, Kuo, Deng, Chunqin, Grover, Rob, Ousmanou, Aliou, Solum, Derek, Tapson, Victor
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
156
Language:
english
Journal:
Chest
DOI:
10.1016/j.chest.2019.08.1070
Date:
October, 2019
File:
PDF, 98 KB
english, 2019
Conversion to is in progress
Conversion to is failed